Novartis (NYSE:NVS) Earns “Neutral” Rating from UBS Group
Novartis (NYSE:NVS – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at UBS Group in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. A number of other research firms also recently commented on NVS. Erste Group Bank restated a “hold” rating on shares of Novartis in […]
Novartis (NYSE:NVS – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at UBS Group in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. A number of other research firms also recently commented on NVS. Erste Group Bank restated a “hold” rating on shares of Novartis in […]
